EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Treatment of sleep-disordered breathing in opioid users with adaptive servo-ventilation: a subgroup analysis of the European READ-ASV registry

Jean-Louis Pepin, Adam V Benjafield, Oliver Munt, Holger Woehrle, Raphael Heinzer, Michael Arzt, READ-ASV Investigators

Journal of Clinical Sleep Medicine · 2025

DOI: 10.5664/jcsm.11652 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Sleep Medicine, 2025. Verfasst von Jean-Louis Pepin und 6 weiteren Autor:innen. Beteiligte Einrichtung: University Grenoble Alpes, INSERM U1300, CHU Grenoble Alpes, HP2 Laboratory, Grenoble, France. Hauptthemen laut MEDLINE: Analgesics, Opioid, Sleep Apnea Syndromes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

STUDY OBJECTIVES: Central sleep-disordered breathing (SDB) is associated with negative health outcomes. Intake of opioids influences stability of breathing and can cause central apneas. Screening for and treatment of SDB is recommended for individuals who use opioids. This subanalysis of the READ-ASV (Registry on the Treatment of Central and Complex Sleep-Disordered Breathing with Adaptive Servo-Ventilation) investigated the effects of adaptive servo-ventilation therapy (ASV) on SDB symptoms in people using opioids. METHODS: Patients initiated on ASV who reported intake of opioids at baseline were included in this analysis of real-world registry data. Patients were prospectively followed-up for 12 months. Disease-specific quality of life was assessed with the Functional Outcomes of Sleep Questionnaire. Sleepiness was measured with the Epworth Sleepiness Scale. Symptomatic patients were defined as having a Functional Outcomes of Sleep Questionnaire score of 10. RESULTS: Eighty-six patients who reported opioid use were included. The population had severe SDB (median apnea-hypopnea index: 55 events/h), the majority (n = 75 [87%]) had comorbidities, and 81.6% (40/49 with follow-up available questionnaires) were symptomatic at baseline. ASV effectively treated SDB (residual median apnea-hypopnea index from device data [apnea-hypopnea index flow]: 1.5 events/h). The Functional Outcomes of Sleep Questionnaire (+1.4 points; P = .003) and Epworth Sleepiness Scale (-3 points; P = .029) scores improved significantly at follow-up compared with baseline, and improvements in disease-specific quality of life were more pronounced in symptomatic patients. CONCLUSIONS: ASV treatment of central breathing disorders in individuals using opioids resolved SDB and was associated with significant improvements in disease-specific quality of life and sleepiness. ASV treatment may therefore be an actionable intervention to counteract the negative effects of opioids on SDB and quality of life. CLINICAL TRIAL REGISTRATION: Registry: ClinicalTrials.gov; Name: Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation (READ-ASV); URL: https://www.clinicaltrials.gov/study/NCT03032029; Identifier: NCT03032029. CITATION: Pepin J-L, Benjafield AV, Munt O, Woehrle H, Heinzer R, Arzt M; for the READ-ASV Investigators. Treatment of sleep-disordered breathing in opioid users with adaptive servo-ventilation: a subgroup analysis of the European READ-ASV registry. J Clin Sleep Med. 2025;21(7):1227-1232.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidSleep Apnea SyndromesHumansMaleFemaleRegistriesMiddle AgedQuality of LifeProspective StudiesSurveys and QuestionnairesTreatment OutcomeEuropeAdult

Stichwörter der Autor:innen

adaptive servo-ventilationcentral sleep apneaopioidsquality of lifesymptomatic

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • University Grenoble Alpes, INSERM U1300, CHU Grenoble Alpes, HP2 Laboratory, Grenoble, France.
  • ResMed Science Center, Sydney, New South Wales, Australia.
  • ResMed Science Center, Munich, Germany.
  • Sleep and Ventilation Center Blaubeuren, Lung Center Ulm, Ulm, Germany.
  • Centre d`Investigation et de Recherche sur le Sommeil, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.

Zitieren

APA

Pepin, J. L., Benjafield, A. V., Munt, O., Woehrle, H., Heinzer, R., Arzt, M., & READ-ASV Investigators (2025). Treatment of sleep-disordered breathing in opioid users with adaptive servo-ventilation: a subgroup analysis of the European READ-ASV registry. Journal of Clinical Sleep Medicine. https://doi.org/10.5664/jcsm.11652

Vancouver

Pepin JL, Benjafield AV, Munt O, Woehrle H, Heinzer R, Arzt M, et al. Treatment of sleep-disordered breathing in opioid users with adaptive servo-ventilation: a subgroup analysis of the European READ-ASV registry. Journal of Clinical Sleep Medicine. 2025. doi:10.5664/jcsm.11652

BibTeX
@article{Pepin2025,
  author = {Pepin, Jean-Louis and Benjafield, Adam V and Munt, Oliver and Woehrle, Holger and Heinzer, Raphael and Arzt, Michael and READ-ASV Investigators, READ-ASV Investigators},
  title = {Treatment of sleep-disordered breathing in opioid users with adaptive servo-ventilation: a subgroup analysis of the European READ-ASV registry},
  journal = {Journal of Clinical Sleep Medicine},
  year = {2025},
  doi = {10.5664/jcsm.11652}
}
Kostenlos starten →